Cardiac surgery

Our cardiac surgery destination for education, evidence, and innovation. We update our information and features frequently. Check back for upcoming physician news and stories.

New cardiac surgery podcast — The Cardiac Exchange

Listen. Learn. Connect. And be inspired.

Listen now

Medical Education

Dr. Bolling reflects on mitral valve repair wet labs at his institution.

Assessing mitral regurgitation

Dr. Martin shares his considerations for assessing mitral regurgitation.


Check our training programs, roundtable discussions, and education resources for the treatment of mitral and tricuspid diseases.

Global Grand Rounds

Grand Rounds are interactive global webcasts delivered by industry-leading experts on a wide range of relevant topics. Listen to Drs. Bavaria and Klautz discuss Today's SAVR Patient: Case Based Discussions Valve Design and Impact on Clinical Outcomes.

Featured Products

Crescent?* Jugular Dual Lumen Catheter

Advancing ECLS therapy, this catheter is designed to optimize your patient's blood flow.

Care and caution should be taken to avoid damage to vessels and cardiac tissue during cannulation or other cardiac surgery procedures.

Avalus? Bioprosthesis

A design platform for long-term durability. Interior-mounted leaflets that leverage our proprietary AOA? tissue treatment.

No clinical data is available which evaluates the long-term impact of AOA treatment in patients.


Strong, proven hemodynamics1,2

Download and read about
the Avalus clinical success.


Mitral repair/ tricuspid repair

A complete portfolio of rigid, semi-rigid, and flexible annuloplasty products designed specifically for a more physiological mitral and tricuspid valve repair.

See Our Options


Aortic, mitral, bovine, and porcine tissue; stented, stentless, and mechanical — we have a full portfolio to meet your needs.

Explore the Possibilities

CABG-enabling? technologies?

Beating heart procedures and sicker coronary patients — we can help you find the right procedure for the right patient.

View Portfolio

Cardiopulmonary and blood management

Innovative and proven, a complete portfolio to optimize your circuit and blood product utilization.

Explore Our Devices


Unmatched selection of cannulae — pediatric and adult — to facilitate insertion and drainage techniques.

Choose Your Cannulae

Extracorporeal life support?

Your mission is our mission — providing you with products designed for ECMO.

See Our Offerings

Surgical ablation?

Achieve transmural lesions with temperature-controlled ablation systems.

See How Temperature Matters

Minimally invasive cardiac surgery?

A video library of MICS techniques and approaches.

Watch Different Techniques

Equipment services and support?

Maximum equipment UPTIME. You expect it, patients rely on it, and we deliver it.

Protect Your Investment

News and Stories

Medtronic has been committed to cannulae for 40 years

Stay up to date with physician experiences, patient stories, and much more

View all Videos and Stories

Connect with Us

Follow us on social media

Stay up to date with new products, innovative stories, and events:

Sign up for updates

Get the latest cardiac surgery updates from Medtronic.

Additional Resources

Contact information

CardioVascular LifeLine

Related pages

Education and training 

View our education and training materials for more information.

?*Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.

Crescent jugular dual lumen catheter is manufactured by MC3, Inc. and exclusively distributed by Medtronic. Crescent jugular dual lumen catheters are not approved in every geography.



Tadokoro N, Fukushima S, Shimahara Y, et al. Comparison of safety and haemodynamic performance between the Avalus? stented aortic valve bioprosthesis and Magna? valve in Japanese patients. Gen Thorac Cardiovasc Surg. July 2021;69(7):1060-1069.


The latest results of the Perigon Study, presented by Prof. Dr. Robert J.M. Klautz during EACTS 2021: Surgical Aortic Valve Replacement with a Stented Pericardial Bioprosthesis: 5-year Outcomes. The PERIGON Pivotal Trial regarding the Avalus valve is a prospective, interventional, nonrandomized, worldwide, multi-site trial, with each center following a common protocol. The study was designed in accordance with the recommendations of the EN ISO 5840:2009 standard for cardiac valve prostheses and the U.S. Food and Drug Administration (FDA) Heart Valve Guidance (2010; DRAFT) and conducted in accordance with the Declaration of Helsinki and good clinical practice guidelines. Valve-related events and deaths were adjudicated by an independent clinical events committee (CEC). All study echocardiograms were analyzed by an independent core laboratory (MedStar Health Research Institute, Washington, D.C.). Safety oversight was provided by an?independent data and safety monitoring board (DSMB). This trial is registered at, NCT02088554.